scieee Science in your language
[en] (orig)

Erythromycin, an inhibitor of mitoribosomal protein biosynthesis, alters the amphotericin B susceptibility of Candida albicans

Abstract

Exposure of the yeast Candida albicans to the macrolide antibiotic erythromycin (C37H67NO13) results in elevated tolerance to the polyene antifungal amphotericin e. Erythromycin displays no fungistatic activity against C. albicans but inhibits the synthesis of cytochromes, particularly cytochrome aa(3). Consequently there is a reduction in aerobic respiration by up to 90% when cells are exposed to 10 mg mL(-1) erythromycin. Cellular ergosterol levels are also severely reduced. Erythromycin inhibits protein biosynthesis in ribosomes (mitoribosomes) located within the mitochondrion of the yeast cell, which results in a disruption of cytochrome biosynthesis with an adverse effect on respiration. The synthesis of ergosterol is oxygen dependent and consequently ergosterol levels are depleted in erythromycin-treated C. albicans. Ergosterol is the target for amphotericin B and since there is less of this sterol in erythromycin-treated cells, there is an increase in tolerance of the antifungal agent. Our work indicates that co- administration of erythromycin and amphotericin B to control bacterial and fungal infections, respectively, may inadvertently lead to an elevation in the tolerance of C. albicans for this antifungal agent.

Read accessible full text

Erythromycin, an inhibitor of mitoribosomal protein biosynthesis, alters the amphotericin B susceptibility of Candida albicans

Author: Geraghty, Patrick,Kavanagh, Kevin
Publisher: Royal Pharmaceutical Society Great Britain
Year: 2003
Source: https://mural.maynoothuniversity.ie/id/eprint/180/1/j022971.pdf
1
Re iew A icle
JPP 2297
JPP 2003 55 000±000
#2003 The Au ho s
Recei ed Sep embe 9, 2002
Accep ed Oc obe 21, 2002
DOI 10.1211/002235702469
ISSN 0022-3573
Medical Mycology Uni , Na ional
Ins i u e o Cellula
Bio echnology, Depa men o
Biology, Na ional Uni e si y o
I eland, Maynoo h, Co. Kilda e,
I eland
Pa ick Ge agh y, Ke in
Ka anagh
Co espondence: K. Ka anagh,
Medical Mycology Uni , NICB,
Depa men o Biology, NUI
Maynoo h, Co. Kilda e, I eland.
E-mail: [email p o ec ed]
Funding: This wo k was
suppo ed by unding o he
Na ional Ins i u e o Cellula
Bio echnology unde PRTLI 3.
Pa ick Ge agh y is a ecipien o
a ellowship om he I ish
Ame ican Pa ne ship.
E y h omycin, an inhibi o o mi o ibosomal p o ein
biosyn hesis, al e s he ampho e icin B suscep ibili y o
Candida albicans
Pa ick Ge agh y and Ke in Ka anagh
Abs ac
Exposu e o he yeas Candida albicans o he mac olide an ibio ic e y h omycin (C
37
H
67
NO
13
) esul s in
ele a ed ole ance o he polyene an i ungal ampho e icin B. E y h omycin displays no ungis a ic ac i i y
agains C. albicans bu inhibi s he syn hesis o cy och omes, pa icula ly cy och ome aa
3
. Consequen ly he e
is a educ ion in ae obic espi a ion by up o 90% when cells a e exposed o 10 mg mL
1
e y h omycin. Cellula
e gos e ol le els a e also se e ely educed. E y h omycin inhibi s p o ein biosyn hesis in ibosomes (mi o ibo-
somes) loca ed wi hin he mi ochond ion o he yeas cell, which esul s in a dis up ion o cy och ome
biosyn hesis wi h an ad e se e ec on espi a ion. The syn hesis o e gos e ol is oxygen dependen and
consequen ly e gos e ol le els a e deple ed in e y h omycin- ea ed C. albicans. E gos e ol is he a ge o
ampho e icin B and since he e is less o his s e ol in e y h omycin- ea ed cells, he e is an inc ease in
ole ance o he an i ungal agen . Ou wo k indica es ha co-adminis a ion o e y h omycin and ampho e icin B
o con ol bac e ial and ungal in ec ions, espec i ely, may inad e en ly lead o an ele a ion in he
ole ance o C. albicans o his an i ungal agen .
In oduc ion
The yeas Candida albicans is an oppo unis ic ungal pa hogen ha is capable o
inducing a ange o supe icial and sys emic in ec ions in he immunocomp omised
hos (Odds 1996). The incidence o in ec ions due o yeas o he genus Candida has
inc eased d ama ically in he las wo decades due, in pa , o he ad en o diseases
such as AIDS (Gil illan e al 1998), he use o immunosupp essi e he apy as a
p e equisi e o o gan ansplan a ion (Lunel e al 1999) and he inc easing numbe o
immunocomp omised pa ien s (P alle e al 1998).
Con en ional he apy o he con ol o in ec ion by C. albicans elies upon he use o
a ange o polyene and azole an i ungal agen s (Munoz e al 2000) ha bind he ungal
memb ane s e ol e gos e ol (Abu-Salah 1996) o dis up s e ol biosyn hesis, espec i ely.
In he case o polyene d ugs, he binding o e gos e ol leads o he o ma ion o po es in
he ungal cell memb ane, me aboli e leakage and subsequen cell dea h (Abu Salah
1996). Azoles dis up e gos e ol syn hesis and induce he o ma ion o oxic s e ol
in e media es, which p o e le hal o he cell (Whi e e al 1998). The polyene an i ungal
agen ampho e icin B is conside ed o be he gold s anda d o an i ungal chemo he apy
and is gene ally ese ed o li e- h ea ening sys emic in ec ions due o i s ex eme
neph o oxici y (Polak 1999). An i ungal he apy can be comp omised by he appea ance
o isola es ha may be inhe en ly esis an o speci ic an i ungals o de elop esis ance
a e p olonged exposu e. The main mechanisms con e ing esis ance o azole d ugs
include inc eased exp ession o e lux pumps, al e ed a ge si es and modi ica ions o
s eps leading o e gos e ol biosyn hesis (Whi e e al 1998). Resis ance o ole ance o
polyene d ugs is clinically a e bu can be media ed by educ ions in he s e ol con en o
he ungal cell memb ane (Kelly e al 1997).
Fungal in ec ions in immunocomp omised pa ien s a e equen ly ound in associa-
ion wi h bac e aemia, which c ea es he possibili y ha d ugs used o con ol bac e ial
in ec ions can ha e an ad e se impac on he he apeu ic ou come o a ungal in ec ion.
E y h omycin (C
37
H
67
NO
13
) is a mac olide an ibio ic o iginally isola ed om
S ep omyces e y heus, wi h ac i i y agains G am-posi i e and G am-nega i e bac e ia.
I con ains a la ge (14-ca bon) lac one ing, which may be
subs i u ed wi h one o mo e suga esidues. E y h o-
mycin unc ions by binding he 50S ibosomal sub-uni
and inhibi ing ansloca ion o he elonga ed pep ide
om one binding si e o ano he on he ibosome hus inhi-
bi ing he addi ion o amino acids o he g owing pep ide
chain (Ib ahim & Bea ie 1973; Gale e al 1981). E y h o-
mycin he apy leads o a modes inc ease in he C. albicans
popula ion o he uppe gas o-in es inal ac o mice
(Samonis e al 2002).
The mi ochond ion is he si e o phospho yla ion o
ADP o ATP and is he si e o ae obic espi a ion wi hin
he ungal cell. Fungal mi ochond ia a e semi-au ono-
mous o ganelles wi hin he cell and con ain ibosomes
( e e ed o as mi o ibosomes), which a e p oka yo ic in
na u e and sensi i e o an ibio ics (eg. chlo amphenicol,
e y h omycin) unlike hei cy oplasmic coun e pa s
(Bo ge e al 2001). Mi o ibosomes a e dis inguishable
om cy oplasmic ibosomes based on sedimen a ion coe -
icien s, wi h he la e ibosomes being 80S and composed
o 60S and 40S sub-uni s while yeas mi o ibosomes a e
app oxima ely74Swi h50Sand37Ssub-uni s(Whi ake &
Danks 1978). An ibio ics ha a ec bac e ia also a ec
ungal mi o ibosmes, inhibi ing he ac i i y o he la ge
50S sub-uni s (Bo ge e al 2001). Recen wo k has
demons a ed ha e y h omycin e a ds he ageing p o-
cess in Saccha omyces ce e isiae by in e e ing wi h mi o -
ibosome unc ion (Holb ook & Menninge 2002);
consequen ly, he e is he possibili y ha e y h omycin
he apy o ea a bac e ial in ec ion could esul in an
al e a ion in he ac i i y o ungal mi o ibosomes wi h
a dele e ious e ec on he ou come o ungal he apy.
The aim o he wo k p esen ed he e was o es ablish he
na u e o he in e ac ion o e y h omycin wi h C. albicans
and o de e mine whe he his has any ole in mode a ing
he suscep ibili y o C. albicans o an i ungal he apy.
Ma e ials and Me hods
Yeas isola es and cul u e condi ions
Candida albicans MEN (se o ype B, o iginally isola ed om
an eye in ec ion and a gi om D D. Ke idge, Camb idge,
UK) was used h oughou his s udy as i is a clinical isola e
wi h a well cha ac e ised esponse o an i ungal agen s.
Cul u es we e g own in YEPD (yeas ex ac ±pep one±D-
glucose) b o h (2% w/ glucose (Sigma-Ald ich Chemical
Co. L d, Do se , UK), 2% w/ bac opep one (Di co
Labo a o ies, MI) and 1% w/ yeas ex ac (Oxoid,
Basings oke, UK)) o he s a iona y phase. S a iona y-
phase cul u es had a ypical cell iabili y o 77.4 6.2%.
Whe e app op ia e, media we e solidi ied by he addi ion o
2% w/ aga (Oxoid). Yeas cul u es we e main ained on
YEPD aga a 4 C and sub-cul u ed e e y 4±6 weeks.
E y h omycin oxici y assay
E y h omycin (Sigma Ald ich) was dissol ed a a concen-
a ion o 500 mg mL
1
in dime hyl sul oxide (DMSO).
This was dilu ed wi h g ow h medium o gi e he app o-
p ia e wo king dilu ions. Yeas cul u es we e g own o he
s a iona y phase (app oxima ely 1.5 10
8
mL
1
)in
YEPD o e nigh a 30 C (200 o a ions pe minu e on
an o bi al shake ). The cells we e coun ed and 5 10
6
cells
we e added o 10 mL o YEPD b o h con aining e y h o-
mycin (Sigma-Ald ich) a 2.5, 5 o 10 mg mL
1
. A DMSO
con ol was included. The cell suspensions we e incuba ed
a 30 C o 24 h, a e which ime he inal cell densi y was
es ablished mic oscopically.
An i ungal suscep ibili y es ing
Yeas cul u es we e g own o he s a iona y phase in an i-
bio ic medium 3 (AB 3) (Oxoid) o e nigh a 30 C and
200 o a ions pe minu e, ha es ed by cen i uga ion
(2220 g o 5 min in a Beckmann GS-6 cen i uge) and
dilu ed o 1 10
6
cells/mL in AB3. Cells (1 10
5
in
100 L) we e added o each well o a 96-well pla e con ain-
ing ampho e icin B (Sigma-Ald ich) dissol ed in AB3 in
se ial dilu ions om 1.25 o 0.0025 gmL
1
. The pla es
we e incuba ed a 30 C o 24 h and he op ical densi y
was ead a 540 nm using a mic opla e eade (Labs
Sys ems iEMS). The MIC80 was de e mined o be he
lowes concen a ion o ampho e icin B equi ed o educe
g ow h by 80% ela i e o he con ol (Mo an e al 1997).
Measu emen o oxygen up ake
S a iona y-phase cells (app oxima ely 1.5 10
8
cells/mL)
g own in YEPD b o h a 30 C o e nigh we e ha es ed,
washed wi h phospha e-bu e ed saline (PBS) and esus-
pended in 0.025 Mphospha e bu e (pH 7.2) a a densi y
o 5 10
8
mL
1
. Oxygen up ake measu emen s we e made
a 30 C, using a Cla k- ype oxygen elec ode. Oxygen
up ake a es we e calcula ed as mol o oxygen consumed
in 30 s pe 10
8
cells.
Cy och ome analysis
S a iona y-phase cells (4 10
9
in o al) we e ha es ed by
cen i uga ion and washed wice in PBS (pH 7.2). Hal o
he sample was oxidised by suspending in 20 mL o 0.3%
w/ sodium hypochlo i e (Sigma-Ald ich). The cells we e
ha es ed and esuspended in 50% / glyce ol. The
emaining 2 10
9
cells we e esuspended in 50% /
glyce ol o which a ew c ys als o sodium di hioni e
(Me ck, Da ms ad , Ge many) we e added o educe he
cy och omes. Reduced-oxidised di e en ial spec a we e
measu ed on a dual beam Ca y IE UV - VISIBLE spec o-
pho ome e o e 500±650 nm.
S e ol ex ac ion and analysis
S e ols we e ex ac ed using he me hod o A hing on-
Skaggs e al (1999) wi h sligh modi ica ions. S a iona y-
phase cells (1 g we weigh ) we e ha es ed and washed
wi h PBS. Cells we e esuspended in 20% w/ KOH and
60% / e hanol and placed in a shaking wa e ba h (80±
90 C) o 90 min. N-hep ane was added o he solu ion,
2Pa ick Ge agh y and Ke in Ka anagh
which was igo ously agi a ed o 10 s and he aqueous
(uppe ) laye was emo ed. The s e ol con en o he hexane
laye was quan i ied using a dual beam spec opho ome e
o e he ange 240±320 nm. An e gos e ol s anda d cu e
was calcula ed o e he ange 100±0.25 gmL
1
and he
ange o linea i y was 0.25±6.25 gmL
1
. The lowes le el
o de ec ion o e gos e ol was 0.1 gmL
1
.
S a is ical analysis
The K uskal±Wallis es was pe o med on he esul s
eco ded om he ampho e icin B suscep ibili y es s,
cell espi a ion and s e ol de e mina ions wi h a s a is ical
package (SigmaS a S a is ical Analysis Sys em, Ve sion
1.00). All se s o esul s displayed a signi ican di e ence
wi h espec o he con ols. In he case o espi a ion
he e is a s a ically signi ican di e ence (P0.03), while
in he ampho e icin B suscep ibili y de e mina ions he e
is a s a ically signi ican di e ence (P50.04). In he s e ol
de e mina ions he di e ence be ween he con ol and he
ea men s is signi ican a P50.001.
Resul s
E ec o e y h omycin on he g ow h
o C. albicans
E y h omycin displays ac i i y agains G am-posi i e
and G am-nega i e bac e ia by in e e ing wi h he unc-
ioning o bac e ial ibosomes which a e s uc u ally
simila o euka yo ic mi o ibosomes (Bo ge e al 2001).
As a consequence, i is possible ha e y h omycin may
display ungis a ic ac i i y agains C. albicans. YEPD
b o h supplemen ed wi h 2.5, 5 o 10 mg mL
1
e y h o-
mycin was inocula ed wi h C. albicans MEN a an ini ial
cell densi y o 5 10
5
mL
1
. Cul u es we e incuba ed
o 24 h a 30 C and he inal cell densi y was de e -
mined by haemocy ome e coun . The esul s indica ed
ha a concen a ions o 2.5±10 mg mL
1
e y h omycin
displayed no subs an ial ungis a ic e ec on C. albicans
(da a no p esen ed).
E ec o e y h omycin on suscep ibili y
o C. albicans o ampho e icin B
The simul aneous occu ence o bac e ial and ungal in ec-
ions in immunocomp omised pa ien s c ea es he possibi-
li y o an ibac e ial and an i ungal d ugs in e ac ing wi h
each o he , o he a ge o ganism o he o he agen , hus
comp omising he apy. Ampho e icin B is a polyene an i-
ungal o iginally isola ed om S ep omyces nodosus and
used in he ea men o li e- h ea ening sys emic mycoses
(Polak 1999). I unc ions by binding e gos e ol in he un-
gal cell memb ane and c ea ing a po e, which leads o loss o
me aboli es and acidi ica ion o he cy oplasm (Abu-Salah
1996). Toxici y assays we e pe o med o es ablish whe he
cells p e- ea ed wi h e y h omycin had al e ed suscep ibil-
i y o ampho e icin B. Cells p e-exposed o e y h omycin
displayed ampho e icin B MIC80 alues inc eased by
app oxima ely 80±110% (Figu e 1). In he case o con ol
cells he MIC80 alue was 0.018 gmL
1
whe eas in cells
p e-g own in he p esence o 2.5, 5 o 10 mg mL
1
e y h o-
mycin he MIC80 anged om 0.033 o 0.038 gmL
1
.
Compa able oxici y assays we e pe o med using he
azole d ugs clo imazole, ke oconazole and miconazole
and no al e a ion in an i ungal suscep ibili y was de ec ed
ollowing p e-g ow h o C. albicans in e y h omycin.
E ec o e y h omycin on cellula espi a ion
o C. albicans
E y h omycin inhibi s he ac ion o mi o ibosomes by
p e en ing p o ein elonga ion a he anspep ida ion
s ep (Gale e al 1981) Ð a p ocess ha could dis up
mi ochond ial espi a ion since a numbe o he sub-
uni s o he cy och omes in ol ed in he elec on ans e
pa hway o espi a ion a e syn hesised on mi o ibosomes
(Whi ake & Danks 1978). The cy och ome p o iles o
cells ea ed wi h e y h omycin we e ob ained o es ablish
he e ec o his d ug on cy och ome biosyn hesis. The
cy och ome p o ile (Figu e 2) o con ol cells indica ed he
p esence o cy och omes aa
3
(602 nm), b (564 nm) and
c (550±554 nm), bu hese we e al e ed in hose cells exposed
o e y h omycin. In pa icula , he cy och ome aa
3
peak
0.05
0.045
0.04
0.035
0.03
0.025
0.02
0.015
0.01
0.005
0
No
e y h omycin
+2.5 mg mL
e y h omycin
–1 +5 mg mL
e y h omycin
–1 +10 mg mL
e y h omycin
–1
Ampho e icin B ( gmL )
µ
–1
**
*
Figu e 1 Suscep ibili y o Candida albicans o ampho e icin B ollowing g ow h in e y h omycin, exp essed as MIC80. Da a a e
means s.e.m. o 5 independen de e mina ions; *P50.04 s no e y h omycin.
E y h omycin al e s he ampho e icin B suscep ibili y o Candida albicans 3
was se e ely dis up ed in he cul u es ea ed wi h 5 and
10 mg mL
1
e y h omycin.
The dis up ion o cy och ome biosyn hesis ollowing
g ow h in e y h omycin has he po en ial o ad e sely a ec
cellula espi a ion, since an incomple e elec on ans e
pa hway would esul in he cells. The espi a ion a es o
cul u es g own in e y h omycin was de e mined using a
Cla k- ype oxygen elec ode. The esul s indica e ha expos-
u e o 2.5, 5 o 10 mg mL
1
e y h omycin dep esses oxygen
consump ion (Figu e 3) Ð in he case o cells ea ed wi h
10 mg mL
1
e y h omycin by up o 90%.
E ec o e y h omycin on e gos e ol con en
o C. albicans
E gos e ol is a key componen o he ungal cell mem-
b ane and he a ge o ampho e icin B (Abu Salah 1996).
The con en ional belie is ha ampho e icin B unc ions
by binding e gos e ol and o ming a po e in he cell mem-
b ane, which leads o leakage o me aboli es and acidi ica-
ion o he cy oplasm. Resis ance o ampho e icin B is a e
bu whe e i has been eco ded he e has been a educed
le el o e gos e ol in he cell memb ane, p o iding ewe
binding si es o he polyene an i ungal (Kelly e al 1997).
The e gos e ol con en o cells ea ed wi h e y h omycin
was de e mined o es ablish whe he a educ ion in e gos-
e ol con en could be a mechanism o he inc eased
ole ance o ampho e icin B. E gos e ol was ex ac ed
om con ol cells and cells g own in he p esence o 2.5,
5 and 10 mg mL
1
e y h omycin, and quan i ied by scan-
ning o e he ange 240±330 nm in a dual beam spec o-
pho ome e . E gos e ol p oduces a cha ac e is ic 4-peak
p o ile in he ange 240±300 nm and his echnique can
be used o quan i y le els wi hin ungal cells (A hing-
on-Skaggs e al 1999). The esul s (Figu e 4) indica e a
educ ion in e gos e ol con en o he h ee e y h omycin-
ea ed cul u es, wi h he g ea es educ ion being e iden
in cul u es ea ed wi h 10 mg mL
1
e y h omycin. Cells
g own in he p esence o 2.5 mg mL
1
e y h omycin had
an e gos e ol le el app oxima ely 66% o he con ol
while hose cells g own in 10 mg mL
1
had an e gos e ol
le el hal he con ol le el.
Discussion
The esul s p esen ed in his pape indica e ha e y h o-
mycin has no signi ican e ec on he g ow h o C. albi-
cans bu ha p e-g ow h o cells in he p esence o
e y h omycin al e s he suscep ibili y o cells o ampho e -
icin B (Figu e 1). E y h omycin ac s on mi ochond ial
p o ein biosyn hesis, which leads o a educ ion in he
No
e y h omycin
+2.5 mg mL
e y h omycin
–1
+5 mg mL
e y h omycin
–1
+10 mg mL
e y h omycin
–1
Wa eleng h (nm)
550 600
Abs 0.1 uni
Figu e 2 Di e en ial spec a o mi ochond ial cy och omes o
Candida albicans ollowing g ow h in e y h omycin. Cy och ome
aa
3
(602 nm), cy och ome b (564 nm) and cy och ome c (550±
554 nm).
No
e y h omycin
+2.5 mg mL
e y h omycin
–1+5 mg mL
e y h omycin
–1+10 mg mL
e y h omycin
–1
120
100
80
40
60
20
0
µmol oxygen consumed
pe 10 cells in 30 s
8
*
*
*
Figu e 3 E ec o e y h omycin on espi a ion o Candida albicans.
Da a a e means s.e.m. o 5 independen de e mina ions; *P0.03
s no e y h omycin.
80
70
60
50
40
30
20
10
0
No
e y h omycin
+2.5 mg mL
e y h omycin
–1+5 mg mL
e y h omycin
–1+10 mg mL
e y h omycin
–1
E gos e ol ( gmL )
µ
–1
*
*
*
Figu e 4 E ec o e y h omycin on e gos e ol con en o Candida
albicans. Da a a e means s.e.m. o 5 independen de e mina ions;
*P50.0001 s no e y h omycin.
4Pa ick Ge agh y and Ke in Ka anagh
amoun o cy och ome aa
3
(Figu e 2). In addi ion, he e is
some dis up ion o cy och omes b and c1. Th ee o he
se en sub-uni s o cy och ome aa
3
a e mi ochond ially
encoded, being syn hesised on mi o ibosomes (Whi ake
& Danks 1978). Cy och ome aa
3
is an in eg al pa o he
elec on ans e pa hway and i s supp ession could
explain he educ ion in oxygen consump ion e iden in
e y h omycin- ea ed cells.
T ea men o C. albicans wi h e y h omycin gi es a
subs an ial educ ion in espi a ion, wi h oxygen up ake
being educed by up o 90% when cells we e g own in
10 mg mL
1
e y h omycin (Figu e 3). Cells exposed o
e y h omycin also show a educ ion in he con en o
e gos e ol (Figu e 4), which is he a ge o ampho e icin B.
Fungal cells equi e oxygen o syn hesise e gos e ol and a
educ ion in espi a o y e iciency o an inabili y o espi e
leads o educed le els o his impo an memb ane s e ol.
Reduc ion in s e ol le els in C. albicans has been iden i ied
p e iously as a mechanism o inc eased g ow h in he
p esence o ampho e icin B (Kelly e al 1997; Whi e e al
1998). Dis up ion o he genes in he e gos e ol biosyn h-
esis pa hway gi es dec eased e gos e ol in Candida glab-
a a and an inc ease in d ug ole ance, pa icula ly o
ampho e icin B (Gebe e al 1995; Vazquez e al 1996).
The equi emen o a unc ional mi ochond ion in e gos-
e ol biosyn hesis is well cha ac e ised and a ises om he
p o ision o NADPH o squalene dime isa ion (Pa ks &
Casey 1995). In addi ion, E g1 encodes squalene epoxi-
dase which con e s squalene o 2,3-oxidosqualene, which
is an oxygen-dependen s ep and in a cell wi h educed
espi a ion he e would be li le syn hesis o e gos e ol
(Daum e al 1998) hus leading o he educed e gos e ol
con en e iden in e y h omycin- ea ed cells.
The wo k p esen ed he e, demons a es ha g ow h o
C. albicans in he p esence o e y h omycin supp esses he
syn hesis o mi ochond ial cy och omes, pa icula ly cy o-
ch ome aa
3
, which in u n leads o a educ ion in cellula
espi a ion. Reduced oxygen up ake leads o a educ ion
in he amoun o e gos e ol in he ungal cell memb ane
due o he equi emen o oxygen in s e ol biosyn hesis.
Reduced e gos e ol le els ha e p e iously been shown o
gi e an ele a ed ole ance o ampho e icin B in C. albicans
(Kelly e al 1997).
The da a p esen ed he e sugges ha co-adminis a ion
o e y h omycin and ampho e icin B o ea bac e ial and
ungal in ec ions, espec i ely, may lead o an ele a ion in
he ole ance o C. albicans o he polyene an i ungal,
wi h po en ially dele e ious consequences o pa ien
eco e y. The use o ampho e icin B is ese ed o se e e
sys emic ungal in ec ions and, as such, ep esen s he las
line o de ence in se e ely immunocomp omised pa ien s
(Polak 1999). Clinical esis ance o his polyene is a e
(Whi e e al 1998). Howe e , ou wo k indica es ha a
d ug ha educes he e gos e ol con en o he ungal
cell memb ane will esul in an ele a ion in he ole ance
o ampho e icin B. This may be su icien o educe he
e icacy o an i ungal he apy and lead o inc eased
pa ien mo ali y. E y h omycin ea men had no e ec
on he ole ance o C. albicans o azole d ugs, which is
no unexpec ed since azoles a ge s eps in he biosyn hesis
o e gos e ol a he han he molecule i sel and conse-
quen ly hei ac ion is no dependen upon he p esence o
e gos e ol in he ungal cell memb ane.
In e ms o pa ien ca e, cau ion should be exe cised in
he adminis a ion o d ugs o he con ol o bac e ial
in ec ions ha may inhibi ungal espi a ion since his
leads o a educ ion in e gos e ol and a concomi an ele a-
ion in ole ance o ampho e icin B. This phenomenon may
be clinically impo an whe e he e is p olonged he apy
wi h e y h omycin (o o he an ibio ics ha in e e e wi h
ungal espi a ion) and ampho e icin B since such condi-
ions may inc ease he p opo ion o he ungal popula ion
exhibi ing ele a ed ole ance o he la e agen .
In conclusion, his wo k demons a es ha e y h omy-
cin inhibi s espi a ion and mi ochond ially encoded cy o-
ch ome biosyn hesis in C. albicans, which leads o a
educ ion in e gos e ol le els in he ungal cell memb ane
and an inc eased ole ance o he an i ungal agen ampho-
e icin B.
Re e ences
Abu-Salah, K. M. (1996) Ampho e icin B: an upda e. B . J.
Biomed. Sci.53: 122±133
A hing on-Skaggs, B. A., Wa nock, D. W., Mo ison, C. J.
(1999) Quan i a ion o e gos e ol con en : no el me hods o
de e mina ion o luconazole suscep ibili y o Candida albi-
cans. J. Clin. Mic obiol.37: 3332±3337
Bo ge , E. C., Sp inge , B., P ammananan, T., Kidan, Y.,
Sande , P. (2001) S uc u al basis o selec i i y and oxici y
o ibosomal an ibio ics. EMBO Rep.21: 318±323
Daum, G., Lees, N. D., Ba d, M., Dickson, R. (1998)
Biochemis y, cell biology and molecula biology o lipids o
Saccha omyces ce e isiae. Yeas 14: 1471±1510
Gale E. F., Cundli e, E., Reynolds, P. E., Richmond, M. H.,
Wa ing, M. J. (1981) The molecula basis o an ibio ic ac ion.
2nd Edi ion, John Wiley & Sons, London
Gebe , A., Hi chcock, C. A., Swa z, J. E., Pullen, F. S.,
Ma sden, K. E., Kwon-Chung, K. J., Benne , J. E. (1995)
Dele ion o he Candida glab a a ERG3 and ERG11 genes:
e ec on cell iabili y, cell g ow h, s e ol composi ion and
an i ungal suscep ibili y. An imic ob. Agen s Chemo he .39:
2708±2717
Gil illan, G. D., Sulli an, D. J., Haynes, K., Pa kinson, T.,
Coleman, D. C., Gow, N. A. R. (1998) Candida dubliniensis:
phylogeny and pu a i e i ulence ac o s. Mic obiology 144:
829±838
Holb ook, Menninge , J. R. (2002) E y h omycin slows ageing
o Saccha omyces ce e isiae. J. Ge on ol.57: 29±36
Ib ahim N. G., Bea ie, D. S. (1973) P o ein syn hesis on ibo-
somes isola ed om a li e mi ochond ia: sensi i i y o e y-
h omycin. FEBS Le .36: 102±104
Kelly, S. I., Lamb, D. C., Kelly, D. E., Manning, N. J., Loe ie , J.,
He ba , H., Schumache , U., Einsele, H. (1997) Resis ance o
luconazole and c oss esis ance o ampho e icin B in Candida
albicans om AIDS pa ien s caused by de ec i e s e ol 
5,6
desa u a ion. FEBS Le .400: 80±82
Lunel, F. M. V, Meis, F. G., Voss, A. (1999) Nosocomial ungal
in ec ions: candidemia. Diagn. Mic obiol. In ec . Dis.34: 213±220
Mo an, G., Sulli an, D. J., Henman, M. C., McC ea y, C. E.,
Ha ing on, B. J., Shanley, D. B., Coleman, D. C. (1997) An i-
ungal d ug suscep ibili ies o o al Candida dubliniensis isola es
E y h omycin al e s he ampho e icin B suscep ibili y o Candida albicans 5

om human immuno-de iciency i us (HIV)-in ec ed and non-
HIV-in ec ed subjec s and gene a ion o s able luconazole
esis an de i a i es in i o. An imic ob. Agen s Chemo he .
41: 617±623
Munoz, P., Bu ilo, A., Bouza, E. (2000) C i e ia used when
ini ia ing an i ungal he apy agains Candida spp. in he in en-
si e ca e uni . In . J. An imic ob. Agen s 15: 83±90
Odds, F. C. (1996) Epidemiological shi s in oppo unis ic and
nosocomial Candida in ec ions: mycological aspec s. In .
J. An imic ob. Agen s 6: 141±144
Pa ks, L. W., Casey, W. M. (1995) Physiological implica ions o
s e ol biosyn hesis in yeas . Ann. Re . Mic obiol.49: 95±116
Polak, A. (1999) The pas , p esen and u u e o an imyco ic
combina ion he apy. Mycoses 42: 355±370
P alle , M. A., Jones, R. N., Messe , S. A. Edmond, M. B.,
Wenzel, R. P. (1998) Na ional su eillance o nosocomial
blood s eam in ec ion due o Candida albicans: equency o
occu ence and an i- ungal suscep ibili y in he SCOPE p o-
g amme. Diagn. Mic obial In ec . Dis.31: 327±332
Samonis, G., Ma aki, S., Ana olio akis, N., Ana olio aki, M.,
Apos olakou, H., Ma gio is, A., Tselen is, Y., Kon oyiannis, D.
(2002) E ec s o e y h omycin, cla i h omycin, oxi h omycin
and azi h omycin on mu ine gu colonisa ion by Candida
albicans. Med. Mycol.40: 139±142
Vazquez, J. A., A ganoza, M. T. Vaishampayan, J. K., Akins, R. A.
(1996) In i o in e ac ion be ween Ampho e cin B and azoles
in Candida albicans. An imic ob. Agen s Chemo he .40: 2511±
2516
Whi e, T. C., Ma , K. A., Bowden, R. A. (1998) Clinical,
cellula and molecula ac o s ha con ibu e o an i- ungal
d ug esis ance. Clin Mic obiol. Re .11: 382±402
Whi ake , P. A., Danks, S. M. (1978) Mi ochond ia: s uc u e,
unc ion and assembly. In eg a ed hemes in biology. Longman,
London
6Pa ick Ge agh y and Ke in Ka anagh